Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
The EPEC-O TM Education in Palliative and End-of-life Care - Oncology Project The EPEC-O Curriculum is produced by the EPECTM Project with major funding provided by NCI, with supplemental funding provided by the Lance Armstrong Foundation. E P E C EPEC – Oncology Education in Palliative and End-of-life Care – Oncology O Module 3f Symptoms – Constipation Constipation . . . Straining Hard stool Sensation of Incomplete evacuation Anorectal obstruction Fewer than 3 BM / week 12 weeks duration > 2 symptoms . . . Constipation Epidemiology Impact: abdominal discomfort / pain, nausea and vomiting Prevalence: up to 90 % among cancer patients treated with opioids Prognosis: can limit prognosis if untreated Management always possible Key points 1. Pathophysiology 2. Assessment 3. Management Pathophysiology Medications Opioids Calcium-channel blockers Anticholinergic Decreased motility Ileus Mechanical obstruction Metabolic abnormalities Spinal cord compression Dehydration Autonomic dysfunction Malignancy Assessment Specifically ask about bowel function Establish what is normal for patient Management General measures Specific measures Regular toileting Softeners Gastrocolic reflex Osmotics Activity Stimulants Lubricants Large volume enemas Stool softeners (detergent laxatives) Sodium docusate Calcium docusate Phospho-soda enema PRN Stimulant laxatives Prune juice Senna Casanthranol Bisacodyl Osmotic laxatives Lactulose or sorbitol Milk of magnesia (other Mg salts) Magnesium citrate Polyethylene glycol Lederle FA, et al. Am J Med, 1990. Attar A, et al. Gut, 1999. Lubricants / enemas Glycerin suppositories Phosphate enema Oil retention enema Tap water, 500 – 1,000 ml Constipation from opioids . . . Occurs with all opioids Pharmacological tolerance develops slowly, or not at all Dietary interventions alone usually not sufficient Avoid bulk-forming agents in debilitated patients Bagnol D, et al. Neuroscience, 1997. . . . Constipation from opioids Combination stimulant / softeners are useful first-line medications Casanthranol + docusate sodium Senna + docusate sodium Prokinetic agents Opioid antagonists Sykes NP. Palliat Med, 2000. E P E C Summary O Use comprehensive assessment and pathophysiology-based therapy to treat the cause and improve the cancer experience